Attila Bielik

A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3 <i>β</i> Inhibitors

Andrea Baki, Attila Bielik, László Molnár et al. · Assay and Drug Development Technologies · 2007 · 120 citations

Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists

István Borza, Sándor Kolok, Anikó Gere et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Functional Selectivity, Medicine, Mechanism Of Action +5

Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications

János Galambos, Attila Bielik, Mikhail Krasavin et al. · Journal of Medicinal Chemistry · 2017 · 29 citations · Full text

Psychiatric Indications, High Throughput, Psychopharmacology +20

Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile

Éva Ágai-Csongor, Katalin Nógrádi, János Galambos et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 21 citations · Full text

Psychiatry, Medicine, Eps Profile +11

Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists

János Galambos, Gábor Wágner, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 21 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +6